Protalix Biotherapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $306k | 170k | 1.80 |
| 2024-09-30 | $43k | 43k | 1.00 |
| 2024-06-30 | $102k | 87k | 1.17 |
| 2024-03-31 | $218k | 173k | 1.26 |
| 2023-12-31 | $444k | 250k | 1.78 |
| 2023-09-30 | $330k | 199k | 1.66 |
| 2023-06-30 | $275k | 137k | 2.00 |
| 2022-12-31 | $11k | 8.2k | 1.37 |
| 2022-06-30 | $9.1k | 8.2k | 1.10 |
| 2022-03-31 | $25k | 24k | 1.05 |
| 2021-06-30 | $3.6M | 1.9M | 1.91 |
| 2020-12-31 | $0 | 50 | 0.00 |
| 2020-09-30 | $0 | 50 | 0.00 |
| 2020-03-31 | $0 | 10 | 0.00 |
| 2019-12-31 | $0 | 10 | 0.00 |